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The ophthalmic, maxillary and mandibular axon branches of the trigeminal ganglion (TG) 
provide cutaneous sensory innervation to the vertebrate face, and multiple families of 
guidance cues amalgamate to direct the navigation of these branches. However, target tissue 
specific guidance cues that discriminately guide the three TG axon branches are unknown. 
Prior work demonstrated that EphAs and ephrin-As could discriminately direct dorsal versus 
ventral motor axon projections into the hindlimb. Similarly, do EphA tyrosine kinases and 
ephrin-A ligands discriminately guide trigeminal ganglion ophthalmic (TGop) lobe versus 
maxillomandibular (TGmm) axon projections into the chick embryo face? The aims of this 
work were two-fold: (1) to identify candidate EphA and ephrin-A molecules during TG axon 
guidance, and (2) to detennine the functional significance of TG axon EphA and ephrin-A 
signalling in vitro. 
This study identified EphA3, EphA4, ephrin-A2 and ephrin-A5 at stages 13, IS and 20, as 
putative guidance cues to TG axons. TG-EphA3 and -ephrin-A5 were identified as putative 
receptors to guidance cues expressed in the target fields. EphA3 receptor was differentially 
expressed, with the TGop lobe expressing higher levels compared to the TGmm lobe. 
However, ephrin-A5 transcript was not differentially expressed between the two ganglion 
lobes. 
In a substratum choice in vitro assay, ephrin-AS-Fc was found to repel approximately 50 % of 
axons growing from stage 20 whole TG explants. This population of axons was identified to 
be from the TGop lobe. The in vitro data supports the contention that during facial 
development there may be trigeminal ganglion lobe specific guidance of TGop in comparison 
to TGmm peripheral sensory axonal projections to target fields coordinated through EphA3 
and ephrin-A2/AS repulsive interactions. 
In vitro, EphA4-Fc caused morphological changes to TG growth cones, which is likely 
mediated through TG ephrin-AS reverse signaling. Furthennore, this study provided in vitro 
evidence that trigeminal ganglion axons were not responsive to EphA4-Fc, possibly implying 
that EphAs expressed in the target fields were not repulsive to ganglionic axons during 
pathfinding. 
The data suggests that EphN ephrin-A interactions may specifically guide TGop projections 
into the ophthalmic process similar to lateral motor axon guidance into the hindlimb. For the 
first time, a model of how EphN ephrin-A interactions and other families of guidance cues 
may act in concert to guide trigeminal ganglion axons is suggested. 
